EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway

Lei Liu, Yanlin Gao, Shiqi Yao

Investigative Opthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.1.45 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2024. Written by Lei Liu and 2 co-authors. Institution: Tianjin Eye Hospital, Tianjin, P. R. China. Major MEDLINE topics: Diabetes Mellitus, Experimental, Diabetic Retinopathy, Prealbumin. Cited 14 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

Transthyretin (TTR) plays a regulatory role in a variety of diabetes-related diseases. The objective of this work was to probe whether TTR affects diabetic retinopathy (DR) through the VEGFA/PI3K/AKT pathway.

Methods

High glucose (HG, 25 mM) was used to treat human retinal microvascular endothelial cells (hRMECs) and C57BL/6J mice were intraperitoneally injected with STZ (50 mg/kg) to construct a DR model. In vitro, the effect of TTR on DR was evaluated by measuring hRMEC proliferation, migration, and angiogenesis. The changes in retinal tissue were observed by hematoxylin and eosin staining in vivo. ELISA, immunohistochemistry, and immunofluorescence staining were used to measure VEGFA or CD31 levels. The levels of all proteins were evaluated through Western blot.

Results

The increase of proliferation, migration, and angiogenesis and decrease of apoptosis in hRMECs caused by HG were notably reversed by TTR. TTR greatly impeded HG-raised VEGFA, PI3K p-p85, and p-AKT in hRMECs. Inhibition of TTR further exacerbated the effect of HG-induced hRMECs. Inhibition of VEGFA reversed the effect of HG-induced hRMECs. VEGFA neutralized the function of TTR on cell proliferation, apoptosis, migration, and angiogenesis in HG-triggered hRMECs. It was further confirmed in vivo that TTR can alleviate the occurrence of DR in diabetic mice models.

Conclusions

TTR significantly restrained the progression of DR via molecular modulation of the VEGFA/PI3K/AKT axis.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic RetinopathyPrealbuminAnimalsHumansMiceEndothelial CellsMice, Inbred C57BLPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor A

Substances

Phosphatidylinositol 3-KinasesPrealbuminProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor AVEGFA protein, humanTTR protein, humanTtr protein, mouse

Authors and institutions

  • Tianjin Eye Hospital, Tianjin, P. R. China.
  • Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin, P. R. China.

Cite

APA

Liu, L., Gao, Y., & Yao, S. (2024). Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.1.45

Vancouver

Liu L, Gao Y, Yao S. Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.1.45

BibTeX
@article{Liu2024,
  author = {Liu, Lei and Gao, Yanlin and Yao, Shiqi},
  title = {Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.1.45}
}
Start for free →